Townhall··Saturday, November 21, 2026, 10:23 AM

New Cancer Study Shows Promising Results: 'Teaching the Immune System Lessons'

New drug FEBP-sTβRII boosts immune attack on tumors, showing 75% success in mice pancreatic cancer study.

Read the full story at Townhall

Opens townhall.com in a new tab.

What do you think?